148 related articles for article (PubMed ID: 3519102)
1. Use of colchicine in Behçet's syndrome.
Sander HM; Randle HW
Cutis; 1986 May; 37(5):344-8. PubMed ID: 3519102
[TBL] [Abstract][Full Text] [Related]
2. [Behçet's disease. Apropos of 32 cases].
Bitar E; Ghayad E; Ghoussoub K; Sinno W; Chams H; Khoury A; Baloglou P; Kallab K; Halaby C; Chemaly R
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):621-4. PubMed ID: 3616444
[TBL] [Abstract][Full Text] [Related]
3. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
Miyachi Y; Taniguchi S; Ozaki M; Horio T
Br J Dermatol; 1981 Jan; 104(1):67-9. PubMed ID: 7459271
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Behçet's syndrome with colchicine].
Pacor ML; Nicolis F; Peroli P; Urbani G; Cortina P; Corrocher R; Lunardi C
Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):257-61. PubMed ID: 2640046
[TBL] [Abstract][Full Text] [Related]
5. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
6. [Behcet's disease. Trial treatment with colchicine].
Bennouna-Biaz F; Heid E; Lazrak B
Ann Dermatol Venereol; 1982; 109(6-7):593-4. PubMed ID: 7187187
[No Abstract] [Full Text] [Related]
7. [Use of colchicine in the treatment of Behçet's disease].
Gasparini G; Sambvani N; Contini D; Brigonzi A
G Ital Dermatol Venereol; 1985; 120(2):159-63. PubMed ID: 4007958
[No Abstract] [Full Text] [Related]
8. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
9. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
Hazen PG; Michel B
Arch Dermatol; 1979 Nov; 115(11):1303-6. PubMed ID: 507883
[TBL] [Abstract][Full Text] [Related]
10. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
[TBL] [Abstract][Full Text] [Related]
11. Behçet's disease in Lebanon: report of 100 cases.
Ghayad E; Tohme A
J Med Liban; 1995; 43(1):2-7. PubMed ID: 8676358
[TBL] [Abstract][Full Text] [Related]
12. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
Hayasaka S; Kawamoto K; Noda S; Kodama T
Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549
[TBL] [Abstract][Full Text] [Related]
13. [Colchicine in the treatment of Behçet's disease (author's transl)].
Mizushima Y; Matsumura N; Mori M; Matsumura Y; Shimizu T; Fukushima B; Mimura Y; Saito K; Sugiura S; Yamana S; Miyake S; Urayama A; Tanaka Y; Miyoshi K; Shirakami A
Ryumachi; 1978 Mar; 18(2):112-6. PubMed ID: 663792
[No Abstract] [Full Text] [Related]
14. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Behçet's disease with colchicine].
Török L; Egyedi K
Hautarzt; 1983 Feb; 34(2):87-8. PubMed ID: 6841085
[No Abstract] [Full Text] [Related]
16. [Treatment of Behçet's disease with immunosuppressive agents and colchicine (author's transl)].
Kadoya M; Okinami S
Nippon Ganka Gakkai Zasshi; 1979 Mar; 83(3):200-6. PubMed ID: 484365
[No Abstract] [Full Text] [Related]
17. [Therapeutic value of colchicine in Behçhet's disease (author's transl)].
Moreno Moraga J; Estrada Saiz RV; Chantres Antoranz MT; Rivas Flores J; Gilsanz García V
Med Clin (Barc); 1981 Jun; 77(1):18-20. PubMed ID: 6454812
[TBL] [Abstract][Full Text] [Related]
18. [Behcet's disease therapy review].
Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome.
Bettiol A; Becatti M; Silvestri E; Argento FR; Fini E; Mannucci A; Galora S; Mattioli I; Urban ML; Malandrino D; Palermo A; Taddei N; Emmi G; Prisco D; Fiorillo C
Clin Exp Immunol; 2021 Dec; 206(3):410-421. PubMed ID: 34562315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
